Evidence map›Paper›PMID 24131717›Full record

ArticleJournal of virology2014

Murine cytomegalovirus protein pM92 is a conserved regulator of viral late gene expression.

Travis J Chapa, Yi-Cheih Perng, Anthony R French, Dong Yu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Decoding murine cytomegalovirus.PLoS pathogens · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mouse CytomegalovirusFrontiers in cellular and infection microbiology · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Travis J ChapaDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Yi-Cheih Perng
Anthony R French
Dong Yu
Washington University in St. Louis · US

Funding

SUPPRESSION OF APOPTOSIS BY HUMAN CYTOMEGALOVIRUS INFECTIONR01CA120768 · NCI · WASHINGTON UNIVERSITY · PI YU, DONG · 2007 to 2011
$1.4M
NCI NIH HHS R01 CA120768NCI NIH HHS R01CA120768
6 · The paper itself

Abstract

In this study, we report that murine cytomegalovirus (MCMV) protein pM92 regulates viral late gene expression during virus infection. Previously, we have shown that MCMV protein pM79 and its human cytomegalovirus (HCMV) homologue pUL79 are required for late viral gene transcription. Identification of additional factors involved is critical to dissecting the mechanism of this regulation. We show here that pM92 accumulated abundantly at late times of infection in a DNA synthesis-dependent manner and localized to nuclear viral replication compartments. To investigate the role of pM92, we constructed a recombinant virus SMin92, in which pM92 expression was disrupted by an insertional/frameshift mutation. During infection, SMin92 accumulated representative viral immediate-early gene products, early gene products, and viral DNA sufficiently but had severe reduction in the accumulation of late gene products and was thus unable to produce infectious progeny. Coimmunoprecipitation and mass spectrometry analysis revealed an interaction between pM92 and pM79, as well as between their HCMV homologues pUL92 and pUL79. Importantly, we showed that the growth defect of pUL92-deficient HCMV could be rescued in trans by pM92. This study indicates that pM92 is an additional viral regulator of late gene expression, that these regulators (represented by pM92 and pM79) may need to complex with each other for their activity, and that pM92 and pUL92 share a conserved function in CMV infection. pM92 represents a potential new target for therapeutic intervention in CMV disease, and a gateway into studying a largely uncharted viral process that is critical to the viral life cycle.

Indexed as

Amino Acid SequenceBase SequenceChromosomes, Artificial, BacterialCytomegalovirusDNA PrimersGene Expression Regulation, ViralImmunoprecipitationMass SpectrometryMolecular Sequence DataPolymerase Chain ReactionSequence Homology, Amino AcidViral ProteinsVirus ReplicationDNA PrimersViral Proteins

Identifiers

PMID24131717
PMCPMC3911726
OpenAlexW2056028897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.